Antibiotice Iasi said it will pay RON8.4 million dividends to the majority shareholder, and RON7.4 million to natural persons and legal entities.
The company reported a profit of RON30 million in 2016.
Antibiotice Iasi has a market capitalization of RON383 million and is majority-owned by Romania’s Health Ministry, with a 53% stake.